Recruiting

mychoiceTM

Sponsor:

Fox Chase Cancer Center

Code:

NCT06222242

Conditions

Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

mychoiceTM

Study Details

Brief summary:

This is a pragmatic, non-randomized mixed-methods evaluation study designed to evaluate the feasibility and acceptability of delivering the mychoiceTM tool to new Medical Oncology patients as well as to more deeply explore its value to patients in their discussion with their provider about clinical trials as a treatment option over the course of their oncology treatment (Effectiveness).

Conditions

Cancer

Study ID

NCT06222242

Start date

Jun 7, 2023

Status verified date

Jan, 2024

Completion date

Jun, 2025

Anticipated

Primary completion date

Jun, 2025

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

18 years of age or over

Able to speak and read English

Medical Oncology patients who have had their initial visit

Have a cell phone number and/or an email in the electronic medical record

Exclusion Criteria

Doesn't not speak or read English

Patients who do not have a cancer diagnosis

Study Design

Enrollment

200 participants

Anticipated

Intervention Model

Single group

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

experimental: mychoiceTM intervention

Single arm study - all participants receive mychoiceTM

Interventions

mychoiceTM

mychoiceTM is an online, educational tool designed to help prepare patients for a conversation with their provider about clinical trials as a treatment option. It consists of text, animations, and videos of real cancer patients sharing their experience with clinical trials. It is not meant to be a recruitment tool, but rather a preparatory tool to promote shared decision making between patients and providers.

Primary outcome measure

  • Feasibility to disseminate the mychoice tool to patients [ Time Frame: 24 months ]
  • Acceptability [ Time Frame: 24 ]
  • Effectiveness [ Time Frame: 24 months ]

Central Contacts and Locations

Central contacts

Linda Fleisher, PhD, MPH

(215) 728-4066linda.fleisher@fccc.edu

Zoe Landau, MPH

215-728-5893zoe.landau@fccc.edu

Locations

Fox Chase Cancer Center

Recruiting

Philadelphia, Pennsylvania, United States, 19111

Contacts

Linda Fleisher, PhD, MPH

(215) 728-4066linda.fleisher@fccc.edu

Zoe Landau, MPH

215-728-5893zoe.landau@fccc.edu

More Information

Sponsor

Fox Chase Cancer Center

Last update posted

Jan 24, 2024

Last verified

Jan, 2024

Keywords

  • cancer

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Fox Chase Cancer Center on 2024-01-24.